Evommune

Targeting the sources of chronic inflammatory diseases.

Evommune is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases. The company is creating game-changing science with the goal of delivering therapies that address symptoms and halt progressive disease.

Visit Site

Related Press